{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:48:22Z","timestamp":1790804902628,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00415-022-11543-8","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T11:03:58Z","timestamp":1674558238000},"page":"1823-1834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19"],"prefix":"10.1007","volume":"270","author":[{"given":"Roberta","family":"Ferrucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cuffaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Capozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rosci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natale","family":"Maiorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Groppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita","family":"Reitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ticozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Silani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1549-3851","authenticated-orcid":false,"given":"Alberto","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"11543_CR1","doi-asserted-by":"publisher","DOI":"10.54103\/milanoup.57","volume-title":"Neurology of COVID-19","author":"A Priori","year":"2021","unstructured":"Priori A, Senior E, Dini M, Deputy E (2021) Neurology of COVID-19. Milano university press, Milan"},{"key":"11543_CR2","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s00259-021-05215-4","volume":"48","author":"E Guedj","year":"2021","unstructured":"Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H et al (2021) 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging 48:2823\u201333","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11543_CR3","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s00259-020-05178-y","volume":"48","author":"A Kas","year":"2021","unstructured":"Kas A, Soret M, Pyatigoskaya N, Habert M-O, Hesters A, Le Guennec L et al (2021) The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging. 48:2543\u201357","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"11543_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.euroneuro.2021.03.019","volume":"46","author":"KW Miskowiak","year":"2021","unstructured":"Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J et al (2021) Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol Elsevier B.V. 46:39\u201348","journal-title":"Eur Neuropsychopharmacol Elsevier B.V."},{"key":"11543_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bja.2020.09.045","volume":"126","author":"HA Baker","year":"2021","unstructured":"Baker HA, Safavynia SA, Evered LA (2021) The \u2018third wave\u2019: impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth 126:44\u201347","journal-title":"Br J Anaesth"},{"key":"11543_CR6","doi-asserted-by":"crossref","unstructured":"Vijiala S, Epiney J-B, J\u00f6hr J, Pincherle A, Meyer MM, Du Pasquier R, et al (2021) Case report: behavioral unresponsiveness in acute COVID-19 patients: the utility of the motor behavior tool-revised and (18)F-FDG PET\/CT. Front Neurol 644848","DOI":"10.3389\/fneur.2021.644848"},{"key":"11543_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet Elsevier Ltd 395:507\u2013513","journal-title":"Lancet Elsevier Ltd"},{"key":"11543_CR8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","volume":"77","author":"AS Zubair","year":"2020","unstructured":"Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol 77:1018\u20131027","journal-title":"JAMA Neurol"},{"issue":"3","key":"11543_CR9","doi-asserted-by":"publisher","first-page":"e20202135","DOI":"10.1084\/jem.20202135","volume":"218","author":"E Song","year":"2021","unstructured":"Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al (2021) Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 218(3):e20202135. https:\/\/doi.org\/10.1084\/jem.20202135","journal-title":"J Exp Med"},{"key":"11543_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3389\/fpsyt.2018.00752","volume":"9","author":"SA Safavynia","year":"2019","unstructured":"Safavynia SA, Goldstein PA (2019) The role of neuroinflammation in postoperative cognitive dysfunction: moving from hypothesis to treatment. Front Psychiatry 9:752. https:\/\/doi.org\/10.3389\/fpsyt.2018.00752","journal-title":"Front Psychiatry"},{"issue":"3","key":"11543_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/joim.13262","volume":"290","author":"R M\u00e9ndez","year":"2021","unstructured":"M\u00e9ndez R, Balanz\u00e1-Mart\u00ednez V, Luperdi SC, Estrada I, Latorre A, Gonz\u00e1lez-Jim\u00e9nez P, et al (2021) Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J Intern Med 290(3):621\u2013631. https:\/\/doi.org\/10.1111\/joim.13262","journal-title":"J Intern Med"},{"key":"11543_CR12","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/brain\/awab009","volume":"144","author":"JA Hosp","year":"2021","unstructured":"Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M et al (2021) Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 144:1263\u20131276","journal-title":"Brain"},{"key":"11543_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100163","volume":"9","author":"M Almeria","year":"2020","unstructured":"Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J (2020) Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain, Behav Immun - Heal 9:100163","journal-title":"Brain, Behav Immun - Heal"},{"key":"11543_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jpsychires.2020.06.022","volume":"129","author":"H Zhou","year":"2020","unstructured":"Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H et al (2020) The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res Elsevier Ltd 129:98\u2013102","journal-title":"J Psychiatr Res Elsevier Ltd"},{"key":"11543_CR15","doi-asserted-by":"publisher","first-page":"L277","DOI":"10.1152\/ajplung.00195.2020","volume":"319","author":"F Potus","year":"2020","unstructured":"Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie AC et al (2020) Novel insights on the pulmonary vascular consequences of COVID-19. Am J Physiol - Lung Cell Mol Physiol 319:L277\u2013L288","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"11543_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/brainsci11020235","volume":"11","author":"R Ferrucci","year":"2021","unstructured":"Ferrucci R, Dini M, Groppo E, Rosci C, Reitano MR, Bai F et al (2021) Long-lasting cognitive abnormalities after COVID-19. Brain Sci 11:1\u201311","journal-title":"Brain Sci"},{"key":"11543_CR17","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S et al (2020) Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol England 19:951\u2013962","journal-title":"Lancet Neurol England"},{"key":"11543_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2967\/jnumed.121.262128","volume":"62","author":"G Blazhenets","year":"2021","unstructured":"Blazhenets G, Schr\u00f6ter N, Bormann T, Thurow J, Wagner D, Frings L et al (2021) Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med 62:910\u2013915","journal-title":"J Nucl Med"},{"key":"11543_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/1352458506070933","volume":"12","author":"MP Amato","year":"2006","unstructured":"Amato MP, Portaccio E, Goretti B, Zipoli V, Ricchiuti L, De Caro MF et al (2006) The Rao\u2019s brief repeatable battery and stroop test: normative values with age, education and gender corrections in an Italian population. Mult Scler J Mult Scler 12:787\u2013793","journal-title":"Mult Scler J Mult Scler"},{"key":"11543_CR20","first-page":"360","volume":"62","author":"P\u00d6 Arnarson","year":"2009","unstructured":"Arnarson P\u00d6, \u00d3lason DP, Sm\u00e1ri J, Sigurdsson JF (2009) The Beck depression inventory second edition (BDI-II): psychometric properties in Icelandic student and patient populations. Taylor & Francis 62:360\u20135","journal-title":"Taylor & Francis"},{"key":"11543_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","volume":"49","author":"E Guedj","year":"2022","unstructured":"Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B et al (2022) EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3. Eur J Nucl Med Mol Imaging 49:632\u2013651","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11543_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/ene.13728","volume":"25","author":"F Nobili","year":"2018","unstructured":"Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P et al (2018) European association of nuclear medicine and european academy of neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol 25:1201\u20131217","journal-title":"Eur J Neurol"},{"key":"11543_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00259-018-4194-x","volume":"46","author":"M Eskian","year":"2019","unstructured":"Eskian M, Alavi A, Khorasanizadeh MH, Viglianti BL, Jacobsson H, Barwick TD et al (2019) Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging 46:224\u2013237","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11543_CR24","doi-asserted-by":"publisher","first-page":"102386","DOI":"10.1016\/j.nicl.2020.102386","volume":"28","author":"E Lindstr\u00f6m","year":"2020","unstructured":"Lindstr\u00f6m E, Oddstig J, Danfors T, J\u00f6gi J, Hansson O, Lubberink M (2020) Image reconstruction methods affect software-aided assessment of pathologies of [18F]flutemetamol and [18F]FDG brain-PET examinations in patients with neurodegenerative diseases. NeuroImage Clin. Elsevier 28:102386","journal-title":"NeuroImage Clin. Elsevier"},{"key":"11543_CR25","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","volume":"57","author":"S Minoshima","year":"2016","unstructured":"Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH et al (2016) SNMMI procedure standard\/EANM practice guideline for amyloid PET imaging of the brain 1.0. J Nucl Med. United States. 57:1316\u201322","journal-title":"J Nucl Med. United States."},{"key":"11543_CR26","first-page":"25","volume":"9","author":"S Salloway","year":"2017","unstructured":"Salloway S, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN et al (2017) Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer\u2019s disease. Assess Dis Monit 9:25\u201334","journal-title":"Assess Dis Monit"},{"key":"11543_CR27","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.tins.2020.10.010","volume":"43","author":"IC Fontana","year":"2020","unstructured":"Fontana IC, Bongarzone S, Gee A, Souza DO, Zimmer ER (2020) PET imaging as a tool for assessing COVID-19 brain changes. Trends Neurosci 43:935\u2013938","journal-title":"Trends Neurosci"},{"key":"11543_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2021.100326","volume":"14","author":"K Duan","year":"2021","unstructured":"Duan K, Premi E, Pilotto A, Cristillo V, Benussi A, Libri I et al (2021) Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19. Neurobiol Stress 14:100326","journal-title":"Neurobiol Stress"},{"key":"11543_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.855868","volume":"16","author":"Y Huang","year":"2022","unstructured":"Huang Y, Ling Q, Manyande A, Wu D, Xiang B (2022) Brain imaging changes in patients recovered from COVID-19: a narrative review. Front Neurosci 16:855868","journal-title":"Front Neurosci"},{"issue":"11","key":"11543_CR30","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3390\/v13112283","volume":"13","author":"T Rudroff","year":"2021","unstructured":"Rudroff T, Workman CD, Ponto LLB (2021) 18F-FDG-PET imaging for post-COVID-19 brain and skeletal muscle alterations. Viruses 13(11):2283. https:\/\/doi.org\/10.3390\/v13112283","journal-title":"Viruses"},{"key":"11543_CR31","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2967\/jnumed.121.262677","volume":"63","author":"A Dressing","year":"2022","unstructured":"Dressing A, Bormann T, Blazhenets G, Schroeter N, Walter LI, Thurow J et al (2022) Neuropsychologic profiles and cerebral glucose metabolism in neurocognitive long COVID syndrome.\". J Nucl Med 63:1058\u20131063","journal-title":"J Nucl Med"},{"key":"11543_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.euroneuro.2022.06.010","volume":"61","author":"M V\u00e9lez","year":"2022","unstructured":"V\u00e9lez M, Falcon\u00ed Paez A, Nicolalde B, Esquetini-Vernon C, Lara-Taranchenko Y, Zambrano K et al (2022) Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan. Eur Neuropsychopharmacol 61:91\u201393","journal-title":"Eur Neuropsychopharmacol"},{"key":"11543_CR33","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00702-021-02371-7","volume":"128","author":"K Danics","year":"2021","unstructured":"Danics K, Forrest SL, Kapas I, Erber I, Schmid S, T\u00f6r\u0151 K et al (2021) Neurodegenerative proteinopathies associated with neuroinfections. J Neural Transm 128:1551\u20131566","journal-title":"J Neural Transm"},{"key":"11543_CR34","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s13365-019-00732-3","volume":"25","author":"T Fulop","year":"2019","unstructured":"Fulop T, Witkowski JM, Larbi A, Khalil A, Herbein G, Frost EH (2019) Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer\u2019s disease? J Neurovirol United States 25:634\u2013647","journal-title":"J Neurovirol United States"},{"key":"11543_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","volume":"604","author":"G Douaud","year":"2022","unstructured":"Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604:697\u2013707","journal-title":"Nature"},{"key":"11543_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/brainsci11030305","volume":"11","author":"M Ciaccio","year":"2021","unstructured":"Ciaccio M, Lo Sasso B, Scazzone C, Gambino CM, Ciaccio AM, Bivona G et al (2021) COVID-19 and Alzheimer\u2019s disease. Brain Sci 11:1\u201310","journal-title":"Brain Sci"},{"key":"11543_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM et al (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21:383\u2013421","journal-title":"Neurobiol Aging"},{"key":"11543_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/imcb.12301","volume":"98","author":"A Webers","year":"2020","unstructured":"Webers A, Heneka MT, Gleeson PA (2020) The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer\u2019s disease. Immunol Cell Biol United States 98:28\u201341","journal-title":"Immunol Cell Biol United States"},{"key":"11543_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.760721","volume":"15","author":"JK Chouhan","year":"2021","unstructured":"Chouhan JK, P\u00fcntener U, Booth SG, Teeling JL (2021) Systemic inflammation accelerates changes in microglial and synaptic markers in an experimental model of chronic neurodegeneration. Front Neurosci 15:760721","journal-title":"Front Neurosci"},{"key":"11543_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104799","volume":"153","author":"D Darif","year":"2021","unstructured":"Darif D, Hammi I, Kihel A, El Idrissi SI, Guessous F, Akarid K (2021) The pro-inflammatory cytokines in COVID-19 pathogenesis: what goes wrong? Microb Pathog 153:104799","journal-title":"Microb Pathog"},{"key":"11543_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac045","volume-title":"Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms","author":"A Rau","year":"2022","unstructured":"Rau A, Schroeter N, Blazhenets G, Dressing A, Walter LI, Kellner E et al (2022) Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Oxford University Press (OUP), Brain"},{"key":"11543_CR42","doi-asserted-by":"crossref","unstructured":"Qin Y, Wu J, Chen T, Li J, Zhang G, Wu D, et al (2021) Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest 131","DOI":"10.1172\/JCI147329"},{"key":"11543_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H 3rd (2010) Alzheimer\u2019s disease and the amyloid-beta peptide. J Alzheimers Dis 19:311\u2013323","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11543-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11543-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11543-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T01:53:32Z","timestamp":1679882012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11543-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["11543"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11543-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"IRB review board has approved the use of humans for this study (CogCov: n. 2020\/ST\/105, Comitato Etico Milano Area 1) and we received consent forms from any participant in a study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}